Xponance’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$196K Buy
2025
Q1
$117K Buy
2024
Q4
$112K Buy
2024
Q3
$104K Buy
2024
Q2
$80.2K Buy
2024
Q1
$58.3K Buy
2023
Q4
$68.2K Buy
2023
Q3
$79.3K Buy
2023
Q2
$78.1K Buy
2023
Q1
$88.5K Hold
2022
Q4
$122K Buy
2022
Q3
$132K Buy
2022
Q2
$107K Buy